Literature DB >> 126653

Complications with the mandril-grown (Sparks) dacron arterial graft.

R W Hallin.   

Abstract

Mandril-grown dacron grafts were successful (22-35 months patency in the iliofemoral position. Because of the tendency of the mandril-grown dacron graft to become aneurysmal (4 of 17 grafts), its use is probably contraindicated in the hypertensive patient. Overall patency is 41 per cent (7 of 17 grafts) at three years. Patency below the inguinal ligament is 18 per cent (2 of 11 grafts) at 29 months. A minimum waiting period of six weeks is required. No infections occurred in this seeries.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 126653

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

1.  The Sparks mandril in femoropopliteal bypass.

Authors:  P N Roberts; B R Hopkinson
Journal:  Br Med J       Date:  1977-11-05

Review 2.  Bioprinting of freestanding vascular grafts and the regulatory considerations for additively manufactured vascular prostheses.

Authors:  Sara Abdollahi; Joseph Boktor; Narutoshi Hibino
Journal:  Transl Res       Date:  2019-06-03       Impact factor: 7.012

Review 3.  Utilizing the Foreign Body Response to Grow Tissue Engineered Blood Vessels in Vivo.

Authors:  Wouter J Geelhoed; Lorenzo Moroni; Joris I Rotmans
Journal:  J Cardiovasc Transl Res       Date:  2017-02-15       Impact factor: 4.132

4.  Mechanically reinforced biotubes for arterial replacement and arteriovenous grafting inspired by architectural engineering.

Authors:  Dengke Zhi; Quhan Cheng; Adam C Midgley; Qiuying Zhang; Tingting Wei; Yi Li; Ting Wang; Tengzhi Ma; Muhammad Rafique; Shuang Xia; Yuejuan Cao; Yangchun Li; Jing Li; Yongzhe Che; Meifeng Zhu; Kai Wang; Deling Kong
Journal:  Sci Adv       Date:  2022-03-16       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.